J9183
HCPCSGemcitabine intravesical sys
Official HCPCS Level II long descriptor
Gemcitabine intravesical system, 225 mg
HCPCS Level II code J9183 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Gemcitabine intravesical sys
Added to HCPCS: 2026-04-01
Nearby codes in J9
- J9173Inj., durvalumab, 10 mg
- J9174Inj, docetaxel (beizray) 1mg
- J9175Elliotts b solution per ml
- J9176Injection, elotuzumab, 1mg
- J9177Inj enfort vedo-ejfv 0.25mg
- J9178Inj, epirubicin hcl, 2 mg
- J9179Eribulin mesylate injection
- J9181Etoposide injection
- J9184Inj gemcitabin (avyxa) 200mg
- J9185Fludarabine phosphate inj
- J9190Fluorouracil injection
- J9196Inj gemcitabine hcl (accord)
- J9198Inj. infugem, 100 mg
- J9200Floxuridine injection
- J9201In gemcitabine hcl nos 200mg
- J9202Goserelin acetate implant
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.